Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000236247

Medchemexpress LLC Benzamide, 2-[[(5-bromo-2-thienyl)methylene]amino]- | 304456-62-0 | 98.0% | 309.18 | C12H9BrN2OS | 100MG
SDP

Supplier:  Medchemexpress LLC HY124447100MG

Encompass_Preferred

BTYNB is a small-molecule inhibitor of the RNA-binding protein IMP1 (IGF2BP1) that disrupts IMP1 binding to c-Myc mRNA and downregulates c-Myc expression in IMP1-positive cancer cell lines. It is supplied and characterized for research applications in molecular and cellular studies.

  • Inhibits IMP1 binding to c-Myc mRNA (IC50 = 5 μM).
  • Shows cellular activity: IC50 2.3 μM (ES-2), 3.6 μM (IGROV-1), 4.5 μM (SK-MEL2).
  • Molecular formula C12H9BrN2OS; molecular weight 309.18 g/mol.
  • Purity 98.0% (NMR) per certificate of analysis.
  • Soluble in DMSO (62.5 mg/mL) and formulatable for in vivo dosing.
  • Store at 4°C; in solution -80°C (6 months) or -20°C (1 month); protect from light.
  • For research use only; not for human or diagnostic use.

Catalog No. 50-002-36247


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.